dm+d
398690007
Medicine Compliance Aid Stability
EmendMerck Sharp and Dohme Ltd
Merck Sharp and Dohme Ltd
Emend
Capsules 80mg, 125mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from moisture
Store in original packaging to protect from moisture.
22 December 2022
Lactation Safety Information
Granisteron, Ondansetron
Neurokinin-receptor antagonist
Use for nausea and vomiting associated with chemotherapy will limit its use in breastfeeding
No published evidence of safety
Low levels anticipated in milk due to the drug’s properties
4 March 2019